Your session is about to expire
← Back to Search
BMS-984923 for Alzheimer's Disease
Study Summary
This trial is researching a new medicine to treat Alzheimer's and possibly slow its progression.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are individuals aged 30 or above eligible to partake in this experiment?
"This medical trial welcomes patients aged between 50 and 80 years old."
Has the FDA sanctioned Dose Under Fed Condition as a viable treatment?
"With limited data available for safety and efficacy assessments, Dose Under Fed Condition was given a rating of 1."
Am I qualified to take part in this research experiment?
"Eligibility criteria for this trial is a diagnosis of Alzheimer's as well as being between 50 and 80 years old. 12 participants will be accepted into the program."
Is this experiment still recruiting participants?
"Evidently, the clinical trial has stopped recruiting participants. As per its summary on clinicialtrials.gov, it was originally posted in October 2023 and last updated April 5th of that same year. Despite this, there are still over 500 medical studies actively searching for patients to enrol at present."
Share this study with friends
Copy Link
Messenger